LUCENTIS

Google image searchProduct monograph

Active ingredient

ranibizumab, 10 MG/ML

DIN: 02296810

Dosage form(s): SOLUTION

Route(s) of administration: INTRAVITREAL

Schedule: Prescription / Schedule D

Company: NOVARTIS PHARMACEUTICALS CANADA INC

Date: 29-MAY-2014

ATC:

• S01 — OPHTHALMOLOGICALS (ATC, ATC/DDD, )
• S01L — OCULAR VASCULAR DISORDER AGENTS (ATC, ATC/DDD)
• S01LA — Antineovascularisation agents (ATC, ATC/DDD)
• S01LA04 — RANIBIZUMAB (ATC/DDD)

Reference brand drug: Lucentis

External Links for Lucentis

Search on Google

• Lucentis side effects
• Lucentis dosage
• ranibizumab side effects
• ranibizumab dosage

Novartis Pharmaceuticals Canada Inc

Go to Novartis website to see drug product details. Sometimes you can find lucentis photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.